In the News November 29, 2017

The Pink Sheet | Indication “Carve In” Allowed Under Generic Labeling “Carve-Out” Authority, US FDA Says

Marc Scheineson is quoted on a U.S. Food and Drug Administration decision allowing new language in abbreviated new drug applications.
Media Contact
Alex Wolfe
Communications Director
Phone: 212.210.9442

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.